Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
To whom it may concern,
After receiving anonymous allegations of research misconduct, the University of Tokyo conducted an investigation of seven articles published by my laboratory during 2005–2015. My colleagues and I have cooperated fully with the investigative committee, providing access to all raw data and participating in direct interviews. After an extensive investigation lasting eight months, the committee reported a number of errors in the handling of data in five of the seven papers in question. As the head of the laboratory, I take ultimate responsibility for these errors, and extend my sincerest apologies to the scientific community for any concern or inconvenience these may have caused. Although we believe that none of the errors affect the main conclusions of any of the reports, we are in contact with the journals in which they were published to determine the most appropriate action we should take for each of the articles (correction, retraction, etc.). In the interests of transparency and a speedy resolution to concerns about these articles, in the following slides I discloses the errors, steps now being taken to resolve them, and the implications for the conclusions of the respective publications. I provide both the originally published data and corrections (below). Again, I apologize deeply for any confusion that these errors may have caused.Sincerely,
Yoshinori Watanabe, PhD Laboratory of Chromosome Dynamics,Institute of Molecular and Cellular Biosciences, The University of Tokyo
コミュニティーの皆様へ 2017.6.17
このたび東京大学に対する匿名の論文不正の告発があり、私どもの研究室から出された7報の
論文について全てのデータに渡る詳細な調査を受けることになり、研究室を上げて全面的に調
査に協力してきました。8ヶ月に及ぶ調査の結果、5報の論文において、いくつかのデータの表示
において不適切な操作およびミスがあったことが調査委員会により指摘されました。私は今回の
調査結果を真摯に受け止め、これらの論文の責任著者として、論文に正確さに欠ける図表が
載ってしまったことに大きな責任を感じております。指摘を受けたいずれの記載も、当該論文自体
の科学的な結論に影響を与えるものではないと考えておりますが、論文の訂正あるいは取り下
げに関しましては、掲載誌と相談した上で最も適切な処置を速やかにとらせて頂く所存です。私
どもの論文疑惑が関連分野の研究者の皆様をいたずらに惑わすことのないように、委員会より
不適切の指摘を受けた記載についての詳細な情報と、それに対する生データに基づいた修正を、
以下に開示いたします。このたびの私どもの軽率な行いにより、研究者コミュニティーの皆様には
大変なご迷惑をおかけしましたことを心より陳謝いたします。
東京大学分子細胞生物学研究所 染色体動態研究分野 渡邊嘉典
Anonymous allegations (and our responses): https://www.dropbox.com/s/3zwoop33r8x0c7k/Accusation%20%28E%29.pdf?raw=1
Two of the 23 allegations are raised in PubPeer: https://pubpeer.com/publications/20383139
https://pubpeer.com/publications/16325576
Correc&onsinourpapers
In Figs. 2e, 2f and 3d, the cells in the representative pictures expressed mCherry-Atb2 (tubulin), whereas the cells used in the quantification did not express mCherry-Atb2. During preparation of the manuscript, we mistakenly used a different population of cells during quantification, and due to this oversight we did not register the latter cells (i.e., those lacking mCherry-Atb2) in the published list of cell strains. However, because both of these cells are similarly arrested at metaphase I by inactivation of APC, the results of the quantification are closely similar and our conclusions are unaffected by this error. We have submitted a request to the journal for correction of the strain list. In Fig 4a, western blot panel of HP1α was improperly processed. We apologize for any confusion that these errors may have caused.
Yamagishi, Y., Sakuno, T., Shimura, M. & Watanabe, Y.Heterochromatin links to centromeric protection by recruiting shugoshin. Nature 455, 251-255 (2008)
HP1α
Fig 4aIP
IgG hSgo1input 0.4%
hSgo1
PP2A-C
HP1α
Actin
Published figure
HP1α
0
0.5
1
1.5
***
p < 0.001(t-test)
Sgo1
sig
nals
(AU
)
0
0.5
1
1.5
***
p < 0.001 (t-test)
Fluo
resc
ence
(AU
)
0
0.5
1
1.5
Fluo
resc
ence
(AU
)
New
mea
sure
men
t(c
ells
exp
ress
ing
mC
herry
–At
b2)
Sgo1-CD-signalSgo1-signal
Sgo1-CD-signal
Fluo
resc
ence
(AU
)
wt swi6∆0
20406080
100120140
sgo1+
Sgo1
sig
nals
(AU
)
sgo1-VE020406080
100120140
Fig. 2e Fig. 2f Fig. 3dSgo1-signal
Fluo
resc
ence
(AU
)
wt020406080100
swi6∆
120140
Publ
ishe
d(c
ells
w/o
mC
herry
-Atb
2)
We confirmed that the quantitative intensities of Sgo1-GFP signal in mCherry-Atb2 expressing cells are nearly identical to those in cells lacking mCherry-Atb2. SD (n = 30 cells).
n.s. (t-test)
Correction
Uncropped image of blottings
PP2A-C
In Fig. 3A, two ChIP datasets (ChIP1 and ChIP2) were improperly combined into a single graph. In the corrected Fig. 3A, ChIP1 and ChIP2 are presented separately. These corrections do not affect the description of the results of the specific experiment or the conclusions of the article as a whole. We apologize for any confusion that this error may have caused.
Errors1) Bir1(WT) and H3-pT3/H3(WT) derive only from ChIP1 but not ChIP2.2) Experiment has not been performed, and should have been indicated as N.D. (not determined). 3) There is a copy error in Swi6(swi6Δ).
WT hrk1∆ swi6∆
zfs1
mes
156
F2m
sp1
imr
Hetero. Eu.
mat
cen
tel
Kin.
zfs1
mes
156
F2m
sp1
imr
Hetero. Eu.
mat
cen
tel
Kin.
zfs1
mes
156
F2m
sp1
imr
Hetero. Eu.
mat
cen
tel
Kin.
0
0.5
1
1.5Bir1 ChIP (%)
0
0.05
0.1
0.15
0.2Hrk1-GFP ChIP (%)
0
0.5
1
1.5
2H3-pT3 ChIP (%) / H3 ChIP (%)
0
5
10
15Swi6 ChIP (%)
Published Fig. 3A
N.D.
N.D.Copy error
Yamagishi, Y., Honda, T., Tanno, Y. & Watanabe, Y. Two histone marks establish the inner centromere and chromosome segregation. Science 330, 239-243 (2010)
Corrected Fig. 3A
(ChIP2)(ChIP1)
0
5
10
15Swi6 ChIP(%)
15
10
5
0
0
0.5
1
1.5Bir1 ChIP(%)
1.5
1
0.5
0
zfs1
mes
156
F2m
sp1
imr
Hetero. Eu.
mat
cen
tel
Kin.
0
1
2
3H3-pT3 ChIP(%)
/ H3 ChIP (%)
3
2
1
0
WT hrk1∆
0
0.5
1
1.5Bir1 ChIP(%)
1.5
1
0.5
0
0
1
2H3-pT3 ChIP(%)
/ H3 ChIP(%)
2
1
0
0
0.1
0.2
Hrk1-GFP ChIP(%)0.2
0.1
0
swi6∆WT
zfs1
mes
156
F2m
sp1
imr
Hetero. Eu.
mat
cen
tel
Kin.
zfs1
mes
156
F2m
sp1
imr
Hetero. Eu.
mat
cen
tel
Kin.
zfs1
mes
156
F2m
sp1
imr
Hetero. Eu.
mat
cen
tel
Kin.
Tada, K., Susumu, H., Sakuno, T. & Watanabe, Y. Condensin association with histone H2A shapes mitotic chromosomes. Nature 474, 477-483 (2011)
In Figs. 3e, 3g, 5a and S16, the western blot panels were not properly processed. We show the corrected panels, which have been reconstructed from the raw data files, are shown here. These corrections do not affect the description of the results of the specific experiment or the conclusions of the article as a whole. We apologize for any confusion that this error may have caused.
EGFP-CAP-HSMC2
Tubulin
CAP-H : WT WTS70A S70A- -
WCE αGFP-IP
Fig 3e
Correction
Fig 3g
CAP-H-pS70
Actin
ZM : - - -+ + +
WCE MBP-H2B
MBP-H2A
Pull-down
CAP-H
MBP-X (CBB)
Correction
CAP-H
H2A
H2BH3
Input1% 0.1%
rIgG-IP
SMC2-IP
SMC2
H2A.ZActin
Fig S16
Correction
CAP-H (Fig 3g)
Tubulin (Fig 3e) Cdc13 (Fig 5a)
SMC2
CAP-H
H3
H2A H2B
H2A.ZActin
Uncropped images of blottings
(Fig S16)
(fliphorizontal)
Fig 5a
Cnd2-pS5Cnd2-GFPCdc13H3-pS10
H3
0 15 30 45 60 75 (min)
Correction
Wehavereceivedanaffirma>vereplyfromNature.
CAP-HH2AH2B
H3
Input1% 0.1%
rIgG-IP
SMC2-IP
SMC2
H2A.ZActin
In Fig. 2A, western blot panels were misprocessed. Yoshinori Watanabe is responsible for this processing. The corrected figure is assembled from blots in the same experiment. This change does not affect the conclusion in the paper. We apologize for any confusion that this error may have caused.
Kagami, A., Sakuno, T., Yamagishi, Y., Ishiguro, T., Tsukahara, T., Shirahige, K., Tanaka, K., Watanabe, Y. Acetylation regulates monopolar attachment at multiple levels during meiosis I in fission yeast. EMBO Rep. 12, 1189-95 (2011)
AcPsm3FLAG
(Psm3)
eso1-H17eso1+
Experiment #4. Acetylation status of cohesin during meiosis
Nucleus number
western
FACS
7
(h)
6
5
4
3
2
1
0
Pat1
inac
tivat
ion
(=0h
) IP:Psm3-FLAG
0 1 2 3 4 5 6 7
PH954 h+ pat1-114 psm3-FLAG’-kanr�
anti-AcPsm3
anti-FLAG
anti-FLAG
anti-Actin
WCE
PH955 h+ pat1-114 eso1-H17 psm3-FLAG’-kanr�
Nucleus numberwestern
IP:Psm3-FLAG
0 1 2 3 4 5 6 7
anti-FLAG
anti-AcPsm3
eso1+3h
IP:Psm3-FLAG
0 1 2 3 4 5 6 7
anti-FLAG
anti-AcPsm3
western (NuPAGE)
anti-AcPsm3 (long)
1 nuc.2 nuc.3,4 nuc.
eso1+�100
8060
4020
0
(%)
0 1 2 3 4 5 6 7 (hr)
1 nuc.2 nuc.3,4 nuc.
eso1-H17�100
8060
4020
0
(%)
0 1 2 3 4 5 6 7 (hr)
anti-AcPsm3anti-FLAG
6/5
6/7 anti-AcPsm3anti-FLAGanti-AcPsm3anti-FLAG
2)
1)
3)
4)
Explanation for the left panels:The immunoprecipitation products prepared from eso1+ cells were analyzed by NuSDS PAGE, and blots were probed first with anti-AcPsm3 and then with anti-FLAG. This experiment was repeated four times, loading the same samples, until the IP samples were exhausted. None of the blots was perfect in terms of band loading and/or transfer, although 2), 3) and 4) are consistent. The red arrows show the published WBs; however, these were inappropriately taken from different WBs, which was not noted in the published figures. Moreover, background signals in the anti-Psm3 WB disappeared because the image contrast was increased in the published panel. Here, we provide a corrected version based on the original data, in which the WBs are indicated by blue arrows. We note that this version also supports the previous conclusion that ‘In meiosis, cohesin is acetylated depending on Eso1 also during late S phase and persists until prophase ‘.
Explanation for the left panels:IP products prepared from eso1-H17 cells were similarly analyzed and shown as a negative control (in both the previous and corrected versions).
This page is a copy of the progress report file by Dr. Kagami (June 10 2011).
Uncropped images of blottings(please note that all gels are flip horizontal)
Psm(2).tif
AcPsm(2).tifFLAG
AcPsm3
eso1+ (2)
Psm(4).tif
AcPsm(4).tif
FLAG
AcPsm3
eso1+ (4)
Psm(H17).tif
AcPsm(H17).tif
FLAG
AcPsm3
eso1-H17
Published
Correction
AcPsm3FLAG
(Psm3)
eso1-H17eso1+
Addedon5thJune
Addedon7thJune
EMBO | Meyerhofstr.1 | 69117 Heidelberg | Germany phone +49 6221 8891 130 fax +49 6221 8891 200 www.embo.org
Dr. Bernd Pulverer Head of Scientific Publications
phone +49 6221 8891 501 fax +49 6221 8891 200
01.05.2017
Dr. Bernd Pulverer | EMBO | Meyerhofstr.1 | 69117 Heidelberg | Germany
YoshinoriWatanabe,PhD
LaboratoryofChromosomeDynamics,
InstituteofMolecularandCellularBiosciences,UniversityofTokyo,
Yayoi1-1-1,Tokyo113-0032,Japan
Re.:EMBOPressassessmentofpotentialimageaberrationinEMBORep.2011;12(11):1189-
95.doi:10.1038/embor.2011.188byYoshinoriWatanabeandcolleagues
DearYoshinori,
IhavewrittenaformallettertotheDr.Takeshitaoftheinvestigationcommitteethatoutlinesourassessmentoftheissuesin
the2011paper.Giventhelackofsignalinoneofthepanelsinparticular,wewouldsuggesttoissueashortcorrigendumthat
incudestheupdatedimagesfrommatchedWesternblotsbasedontheoriginalsourcedataoffigure2Aa.
Wewouldliketoinviteyoutoissuethistextandwewillaimtopublishitasfastaspossibleasacorrigenduminthejournal.
Tosummarizethiscase,youalertedustoapparentproblemsinfig2AonMarch29th2017,apparentlybasedonissues
pointedoutaspartoftheinstitutionalinvestigation.Weassessedallofthepublishedimagesofthepaperandfoundnoother
problemsthanthosenotedbyyouinfig2A.Regardingfig2A,weconcludethatthecontrastisoverlyaccentuatedinthe
Westernblotpanelsintheleftpartofthefigure,whichleadstoalossoflinearsignal,limitingthequantitativeinformation
thatcanbederivedfromtheimages.
YoualsorightlynotedthatthereisnoapparentsignalinthetoprighthandWesternblotpaneloffig2A.Thismaybedue
eithertothecompleteabsenceofexperimentaldataorimagesthatwereover-contrastedtothepointwhereallsignalislost
attheresolutionofthepublishedimage.Eitherway,panelswithnodetectabledataarenotinformative.Inthiscase,our
viewisthattheproblemismostlikelyeitherduetoamistakeortopoorimageprocessing,ratherthanintentional
falsification.
YoualsoprovidedasetofPowerPointfilesincludingsomeJapaneselanguageannotationsthatwecouldnotdecipher.These
filesappeartorepresentnotestakenatthetimebythepostdocwhoperformedtheexperimentsandyouconfirmedthat
thesefilesweresavedin2011.Youalsosuppliedasetofdigitalimagefilesthatapparentlyrepresentunprocessedsource
datascans.Wehaveassessedallofthesefilesandconcludethattheyareconsistentwithyourclaimthatyouranfoursetsof
Westernblotswiththesamesetofsamplesinparallelandprocessedtheseblotsinparallel(i.e.theyallderivedfromasingle
experiment).Theblotsunderlyingthedifferentpanelswereprobablyprocessedsomewhatdifferently,resultinginthe
differentcontrastandbackgroundnotedinthepublishedfigure.Thisclearlylimitsthequantitativecomparisonspossible
betweenthepanels,butnonethelessallowsforqualitativecomparisons.Theconclusionsinthepaperderivedfromthisfigure
arelargelyqualitativeandwethereforeseenocompellingreasontodoubttheseconclusions.Wedonothaveaccessto
primarylab-bookrecordsorindeedtheprimaryphotographsoftheWesternblots,theWesternblotsthemselvesor
remainingdenaturedproteinsamples,andassuchwecannotrunafullresearchinvestigationatEMBOPress.However,we
seenoreasontodoubtyourexplanations.
Werecommendissuingacorrigendumprimarilytopointtothefactthatthetoprightpanellackssignalandtoshowthe
correctpanels.Aspartofthiscorrigendum,wewouldalsoinviteyoutonotethattheWesternblotsinfig2Awerederived
fromthesamesamples,runatthesametime,butthatthesewereconcatenatedtoassemblethepublishedfigure.This
EMBO | Meyerhofstr.1 | 69117 Heidelberg | Germany phone +49 6221 8891 0 fax +49 6221 8891 202 [email protected] www.embo.org
resultedindifferentialcontrastandexposuresinthepublishedfigures,limitingthequantitativeinformationcontentofthe
figure,butnotpersetheconclusionsderived.
OntheEMBOPressscaleofimageaberrations(seeTheEMBOJournal(2015)34,2483-2485),thiswouldbealevel1,thelowestlevelon the scale we use to classify image and data aberrations (http://embor.embopress.org/classifying-image-aberrations).Thus,ourviewisthatthebasicconclusionsofthisfigure,andthereforethepaperasawhole,stand.Tobeclear,wedonotregarditasbestpracticetomixandmatchWesternblotpanelstoobtainthemost‘compelling’figure.
However,aslongasitistruethatthematchedblotsallderivedfromasinglesetofsamplesfromthesameexperiment,we
seenocaseofespeciallypoorexperimentalrigour,orindeedtoconcludeformalwrongdoing.
PleasenotethatwealsoassessedthefiguresofotherpapersthatyoukindlypublishedinjournalsthatbelongtotheEMBOPressgroup(listedbelow).Wedetectednootherissuesofimageaberrationormanipulationbasedonourstandardscreening
process.
Yourssincerely,
BerndPulverer,Ph.D.
HeadofScientificPublications;ChiefEditor,TheEMBOJournal;ActingChiefEditor,EMBOreports
OtherpapersassessedbyEMBOPressstandardimageforensicprocesses:
ThecohesinREC8preventsillegitimateinter-sistersynaptonemalcomplexassembly.IshiguroK,WatanabeY.EMBORep.2016Jun;17(6):783-4.doi:10.15252/embr.201642544.AcetylationregulatesmonopolarattachmentatmultiplelevelsduringmeiosisIinfissionyeast.KagamiA,SakunoT,YamagishiY,IshiguroT,TsukaharaT,ShirahigeK,TanakaK,WatanabeY.EMBORep.2011Oct28;12(11):1189-95.doi:10.1038/embor.2011.188.Anewmeiosis-specificcohesincompleximplicatedinthecohesincodeforhomologouspairing.IshiguroK,KimJ,Fujiyama-NakamuraS,KatoS,WatanabeY.EMBORep.2011Mar;12(3):267-75.doi:10.1038/embor.2011.2Auroracontrolssisterkinetochoremono-orientationandhomologbi-orientationinmeiosis-I.HaufS,BiswasA,LangeggerM,KawashimaSA,TsukaharaT,WatanabeY.EMBOJ.2007Oct31;26(21):4475-86.Rec8cleavagebyseparaseisrequiredformeioticnucleardivisionsinfissionyeast.KitajimaTS,MiyazakiY,YamamotoM,WatanabeY.EMBOJ.2003Oct15;22(20):5643-53.
In figs. 2C, S13C and S15A, the representative images for comparison were captured under different imaging conditions. In fig. S8B, S11F, S12B, the images used for compared were not adjusted using identical settings. In fig. S8A, the dot blots were mislabeled and not properly adjusted for contrast. We show corrected images or explanation here. Given that quantifications were performed using the original images, we believe that the changes in the representative images do not affect the conclusions of the paper. However, as this paper has a number of errors, we are contacting the journal to inquire whether extensive correction or retraction is more appropriate. We apologize for any confusion that these errors may have caused.
Tanno, Y., Susumu, H., Kawamura, M., Sugimura, H., Honda, T., & Watanabe, Y. The inner centromere-shugoshin network prevents chromosomal instability. Science 349, 1237-1240 (2015)
K9me3 blot
K9me3S10ph blotμg: 1
0.5
0.25
0.12
5 1
0.5
0.25
0.12
5
α-K9me3 α-K9me3S10ph
Published
K9me3 blot
K9me3S10ph blot
μg: 1.6
0.8
0.4
0.2
α-K9me3 α-K9me3S10ph
1.6
0.8
0.4
0.2
Corrected
fig S8A fig S8B Published
fig. S8In fig. S8A, western blots were mislabeled and not properly adjusted for contrast. In figure S8B, the pictures to be compared were not equally adjusted. Corrected panels are shown here. Panels for H3K9me3 staining were removed from fig S8B because they are shown in Figure 2C. Accordingly the figure legend is changed. These corrections do not affect either the description of the results in the paper or the conclusions contained therein.
K9me3 blot
K9me3S10ph blotμg: 1.
6 0.
8 0.
4
0.2
α-K9me3 α-K9me3S10ph
1.6
0.8
0.4
0.2
Published
Corrected
HeLa-1 (CIN-) HeLa-2 (CIN+)
CENP-C DNA
H3K9me3
H3K9me3S10ph
B
K9me3 blot
K9me3S10ph blotμg: 1 0.
5 0.
25
0.12
5 1 0.5
0.25
0.
125
α-K9me3 α-K9me3S10ph A
A
H3K9me3S10ph
CENP-C DNA
B HeLa-1 (CIN-) HeLa-2 (CIN+)
CENP-C DNA
H3K9me3
H3K9me3S10ph
Corrected
fig. S8�In fig. S8A, western blots were mislabeled and not properly adjusted for contrast (faint spot disappeared). In fig. S8B, the pictures to be compared were not equally adjusted. Correctly adjusted pictures are produced from the original files and shown here. These corrections do not affect either the description of the results in the paper or the conclusions contained therein.�
K9me3 blot�
K9me3S10ph blot�μg: 1.
6 0.
8 0.
4
0.2
α-K9me3 α-K9me3S10ph
1.6
0.8
0.4
0.2
Published
Corrected
HeLa-1 (CIN-)� HeLa-2 (CIN+)�
CENP-C DNA
H3K9me3�
H3K9me3S10ph�
B
K9me3 blot�
K9me3S10ph blot�μg: 1 0.
5 0.
25
0.12
5 1 0.5
0.25
0.
125
α-K9me3 α-K9me3S10ph A
A
B
HeLa-1 (CIN-) HeLa-2 (CIN+)
H3K9me3 CENP-C
H3K9me3
CENP-C S10ph
fig S11F Published Corrected
Published� Corrected�
Control� NCDM-32b�
DNA
CENP
-C
H3K9
me3
DNA
SG
O1
CENP
-C
In fig. S11F, the pictures to be compared were not equally adjusted. Correctly adjusted pictures, which well reflect the quantification data, are shown here.�
fig. S11F�
Control� NCDM-32b�
DNA
CENP
-C
H3K9
me3
DNA
SG
O1
CENP
-C
Published� Corrected�
Control� NCDM-32b�
DNA
CENP
-C
H3K9
me3
DNA
SG
O1
CENP
-C
In fig. S11F, the pictures to be compared were not equally adjusted. Correctly adjusted pictures, which well reflect the quantification data, are shown here.�
fig. S11F�
Control� NCDM-32b�
DNA
CENP
-C
H3K9
me3
DNA
SG
O1
CENP
-C
Cold-treated and non-treated samples were prepared in parallel. The exposure conditions for filming tubulin signals are adjusted by the signal strength of each non-treated sample and applied to the cold-treated sample. Accordingly, the exposure time was different among samples. Quantification was done by the ratio between cold-treated and non-treated samples and normalized to that of control. The differences in exposure time compensate for differences in the intensity of staining between independent non-treated samples. Because imaging conditions were adjusted in a way that non-treated samples showed similar intensity, representative pictures of the cold-treated samples do reflect quantitative differences in the different conditions.
Explanation
fig S15A
HeL
a-2-
HA-
Suv3
9-C
B W
T Δ
SET
H3K9me3CENP-C DNA
Published Corrected
HeL
a-2-
HA-
Suv3
9-C
B W
T Δ
SET
H3K9me3CENP-C DNA
Fig 2C CorrectedPublished
HeL
a-1
(CIN
-)H
eLa-
2 (C
IN+)
H3K9me3CENP-C DNA
HC
T116
H
4C
ontro
lsi
RAD
21
Tubulin CENP-C DNA
Published
fig S13C
Col
d st
able
mic
rotu
bule
0
3
1
2
HCT116
**
H3K9me3 DNA CENP-C
HeL
a-1
(CIN
-) H
eLa-
2 (C
IN+)
0%
50%
100%100
50
0
Anap
hase
seg
rega
tion
erro
rs (%
)�
StructureAttachment
HT10
80
HeLa
-3
293T
A172
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
SW48
0
Lovo
HT29
Caco
2
Attachment defect
CIN+
Structure defect
Fig. 1A�
Published graph(fig. S6)
Incorrect error bars
The graph in fig. S6 was assembled by extracting data from Fig. 1A. In this process, we have made a mistake in error bar addition. Corrected panel is shown here. �
Corrected graph(fig. S6)
fig. S6�
0%
50%
100%100
50
0
Anap
hase
seg
rega
tion
erro
rs (%
)� StructureAttachment
HT10
80
HeLa
-3
293T
A172
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
SW48
0Lo
voHT
29Ca
co2
Attachment defect
CIN+
Structure defect
0%
50%
100%100
50
0
Anap
hase
seg
rega
tion
erro
rs (%
)�
StructureAttachment
HT10
80
HeLa
-3
293T
A172
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
SW48
0
Lovo
HT29
Caco
2
Attachment defect
CIN+
Structure defect
Fig. 1A�
Published graph(fig. S6)
Incorrect error bars
The graph in fig. S6 was assembled by extracting data from Fig. 1A. In this process, we have made a mistake in error bar addition. Corrected panel is shown here. �
Corrected graph(fig. S6)
fig. S6�
0%
50%
100%100
50
0
Anap
hase
seg
rega
tion
erro
rs (%
)� StructureAttachment
HT10
80
HeLa
-3
293T
A172
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
SW48
0Lo
voHT
29Ca
co2
Attachment defect
CIN+
Structure defect
Cells
with
coh
esio
n lo
ss a
fter
MG
132
arre
st (%
)
0
100
25
50
75
H4
HCT116
Cont
rol
siRAD
21
* * *
Co ntro l
s iS cc 1 H
4
0
2 5
5 0
7 5
1 0 0
Cells
with
coh
esio
n lo
ss a
fter
MG
132
arre
st (%
)
0
100
25
50
75
H4
HCT116
Cont
rol
siRAD
21
* * *
Published graph(± SEM)
Corrected graph(± SD)
fig. S13��fig. S6�
0%
50%
100%100
50
0
Anap
hase
seg
rega
tion
erro
rs (%
) StructureAttachment
HT10
80
HeLa
-3
293T
A172
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
SW48
0Lo
voHT
29Ca
co2
Attachment defect
CIN+
Structure defect
Figure S6
01020304050
01020304050
0102030405060
293TU2OSA431
(iii) Doubly defective
Atta
chm
ent d
efec
t (%
)
(i) H3K9me3 defective
Atta
chm
ent d
efec
t (%
)
A
0102030405060
HCC1937(BRCA1)
MCF7HeLa-2 HeLa-3 GM637
- Su
v39
Soro
rin
HCT116(siRB)
(ii) Cohesindefective
Atta
chm
ent d
efec
t (%
)
0
10
20
30
40
50
******
**
***
**** ** **
Figure 4 A
- Su
v39
Soro
rin - Su
v39
Soro
rin - Su
v39
Soro
rin- Su
v39
Soro
rin
- Su
v39
Soro
rin -
Doub
le
Suv3
9 So
rorin
0
10
20
30
40
50
-
Doub
le
Suv3
9 So
rorin
-
Doub
le
Suv3
9 So
rorin
Published graph(fig. S6)
Incorrect error bars
Corrected graph(fig. S6)
Fig. 1A�
Science 349, 1237-1240 (2015)
0%
50%
100%100
50
0
Anap
hase
seg
rega
tion
erro
rs (%
) StructureAttachment
HT10
80
HeLa
-3
293T
A172
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
SW48
0Lo
voHT
29Ca
co2
Attachment defect
CIN+
Structure defect
Figure S6
0102030405060
(i) H3K9me3 defective
Atta
chm
ent d
efec
t (%
)
A
0102030405060
HCC1937(BRCA1)
MCF7HeLa-2 HeLa-3 GM637
- Su
v39
Soro
rin
**
**
***
Figure 4 A
- Su
v39
Soro
rin - Su
v39
Soro
rin - Su
v39
Soro
rin- Su
v39
Soro
rin
01020304050
01020304050
293TU2OSA431
(iii) Doubly defective
Atta
chm
ent d
efec
t (%
)
HCT116(siRB)
(ii) Cohesindefective
Atta
chm
ent d
efec
t (%
)
0
10
20
30
40
50
**** ** **
- Su
v39
Soro
rin -
Doub
le
Suv3
9 So
rorin
0
10
20
30
40
50
-
Doub
le
Suv3
9 So
rorin
-
Doub
le
Suv3
9 So
rorin
****
*
Original graph and data(before revision)�Published graph Corrected graph
(all ± SEM)
In summary, both ICS network defects and mi-totic segregation errors are rescued by restor-ing H3K9me3 and/or cohesin in seven of nineCIN+ cells, which suggests that these two path-ways are important CIN-susceptible targets inhuman cells.Our study reveals that impairment in the ICS
network prevails among human CIN+ cell linesand acts as a key molecular mechanism to gen-erate CIN. Although numerous cellularmutationsmay influence chromosome segregation, onlymu-tations that moderately impair chromosome seg-regationwill establish CIN+ cells, which divide butexhibit genomic instability. In fact, the depletionof a core component of the ICS network (BUB1,SGO1, or the CPC) from cells provokes seriousmitotic defects that lead to lethalmitosis, whereashypomorphicmutations in the ICS network com-ponents cause CIN in cultured human cells andpromote tumorigenesis in mice (28, 29). None-
theless, mutations in components of the ICSnetwork (BUB1, SGO1, CPC) are rare in humancancer genomes (30), implying that the path-ways regulating the ICS network, rather than itscore components, might be genetically or epi-genetically alteredduring tumorigenesis. Indeed,we detected an ICS network defect associatedwith chromosome segregation errors in a patientwith non–small cell lung cancer (fig. S16). Futurestudies, including the inspection of a substantialnumber of clinical samples, will validate the po-tential linkage between ICS network defects andCIN in tumors.
REFERENCES AND NOTES
1. C. Lengauer, K. W. Kinzler, B. Vogelstein, Nature 396, 643–649(1998).
2. R. A. Burrell, N. McGranahan, J. Bartek, C. Swanton, Nature501, 338–345 (2013).
3. N. J. Ganem, S. A. Godinho, D. Pellman, Nature 460, 278–282(2009).
4. T. D. Barber et al., Proc. Natl. Acad. Sci. U.S.A. 105,3443–3448 (2008).
5. S. F. Bakhoum, G. Genovese, D. A. Compton, Curr. Biol. 19,1937–1942 (2009).
6. D. Cimini et al., J. Cell Biol. 153, 517–527 (2001).7. S. L. Thompson, D. A. Compton, J. Cell Biol. 180, 665–672
(2008).8. R. A. Burrell et al., Nature 494, 492–496 (2013).9. S. F. Bakhoum et al., Curr. Biol. 24, R148–R149 (2014).10. K. E. Gascoigne, S. S. Taylor, Cancer Cell 14, 111–122
(2008).11. D. A. Solomon et al., Science 333, 1039–1043 (2011).12. J. R. Daum et al., Curr. Biol. 21, 1018–1024 (2011).13. M. A. Lampson, I. M. Cheeseman, Trends Cell Biol. 21, 133–140
(2011).14. T. U. Tanaka, EMBO J. 29, 4070–4082 (2010).15. Y. Watanabe, Nat. Rev. Mol. Cell Biol. 13, 370–382 (2012).16. T. S. Kitajima et al., Nature 441, 46–52 (2006).17. Y. Tanno et al., Genes Dev. 24, 2169–2179 (2010).18. J. Lee et al., Nat. Cell Biol. 10, 42–52 (2008).19. K. J. Salimian et al., Curr. Biol. 21, 1158–1165 (2011).20. Y. Yamagishi, T. Sakuno, M. Shimura, Y. Watanabe, Nature
455, 251–255 (2008).21. T. Hirota, J. J. Lipp, B. H. Toh, J. M. Peters, Nature 438,
1176–1180 (2005).22. A. L. Nielsen et al., Mol. Cell 7, 729–739 (2001).23. P. A. Cloos et al., Nature 442, 307–311 (2006).24. H. Liu, L. Jia, H. Yu, Curr. Biol. 23, 1927–1933 (2013).25. J. M. Peters, A. Tedeschi, J. Schmitz, Genes Dev. 22,
3089–3114 (2008).26. M. L. Suvà, N. Riggi, B. E. Bernstein, Science 339, 1567–1570
(2013).27. T. Nishiyama et al., Cell 143, 737–749 (2010).28. K. Jeganathan, L. Malureanu, D. J. Baker, S. C. Abraham,
J. M. van Deursen, J. Cell Biol. 179, 255–267 (2007).29. H. Y. Yamada et al., Cell Cycle 11, 479–488 (2012).30. M. S. Lawrence et al., Nature 505, 495–501 (2014).
ACKNOWLEDGMENTS
We thank S. Hauf for critically reading the manuscript; T. Akiyama,Y. Gotoh, K. Shirahige, T. Hirota, K. Miyagawa, A. Enomoto,M. Ohsugi, T. Kitamura, H. Suzuki, and T. Ohta for kindly providingmaterials; K. Funai for clinical arrangements; Y. Hirabayashi,Y. Kanki, S. Koitabashi, M. Okada, T. Kahyo, A. R. Maia, R. Nakato,and D. Izawa for valuable technical advice; and all members of ourlaboratory, particularly Y. Yamagishi, for their valuable support anddiscussions. Supported by JSPS KAKENHI grants 24770180 and26440093 (Y.T.), a JSPS research fellowship (H. Sus.), and MEXTKAKENHI grants S-001 (H. Sug.) and 25000014 (Y.W.).
SUPPLEMENTARY MATERIALS
www.sciencemag.org/content/349/6253/1237/suppl/DC1Materials and MethodsFigs. S1 to S16References (31–40)
10 November 2014; accepted 5 August 201510.1126/science.aaa2655
1240 11 SEPTEMBER 2015 • VOL 349 ISSUE 6253 sciencemag.org SCIENCE
Fig. 4. Promotion of H3K9me3 andcohesin association with chromatinsuppress CIN. (A) The percentage ofanaphases showing attachment defectswas measured in the indicated cellsexpressing HA-Suv39H1-CENP-B and/orGFP-sororin. Error bars, SEM from threeindependent experiments. **P < 0.01,***P < 0.001, one-way ANOVA withBonferroni’s multiple comparisons test
relative to non-expressing cells. (B) Suppression of ICS network defects and CIN in various CIN+ cell lineswith defects (–) in H3K9me3 and chromatin-associated cohesin. The solid box indicates the suppression.
RESEARCH | REPORTSCorrected 18 September 2015; see full text.
Incorrect error bars
(± SD)
(± SD)
Figure 4A
Figure 2A
11.21.41.61.82
2.2
RPE1
HCT1
16He
La-1
HT10
80
HeLa
-3
293T
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
CIN- CIN+ (Attachment defect)
HP1α level in metaphase (centromere/arm)
* * * * *
* * * * * * * * * * * *
* * * * * * *
1.01.2
2.02.2
1.41.61.8
Corrected graph
11.21.41.61.82
2.2
RPE1
HCT1
16He
La-1
HT10
80
HeLa
-3
293T
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
CIN- CIN+ (Attachment defect)
HP1α level in metaphase (centromere/arm)
* * * * * * * * * * * * * * * *
* * * * * *
* *
1.01.2
2.02.2
1.41.62.2
Published graph
Incorrect error bars
Cells
with
coh
esio
n lo
ss a
fter
MG
132
arre
st (%
)
0
100
25
50
75
H4
HCT116
Cont
rol
siRAD
21
* * *
Co ntro l
s iS cc 1 H
4
0
2 5
5 0
7 5
1 0 0
Cells
with
coh
esio
n lo
ss a
fter
MG
132
arre
st (%
)
0
100
25
50
75
H4
HCT116
Cont
rol
siRAD
21
* * *
Published graph(± SEM)
Corrected graph(± SD)
fig. S13��fig. S6�
0%
50%
100%100
50
0
Anap
hase
seg
rega
tion
erro
rs (%
) StructureAttachment
HT10
80
HeLa
-3
293T
A172
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
SW48
0Lo
voHT
29Ca
co2
Attachment defect
CIN+
Structure defect
Figure S6
01020304050
01020304050
0102030405060
293TU2OSA431
(iii) Doubly defective
Atta
chm
ent d
efec
t (%
)
(i) H3K9me3 defective
Atta
chm
ent d
efec
t (%
)
A
0102030405060
HCC1937(BRCA1)
MCF7HeLa-2 HeLa-3 GM637
- Su
v39
Soro
rin
HCT116(siRB)
(ii) Cohesindefective
Atta
chm
ent d
efec
t (%
)
0
10
20
30
40
50
******
**
***
**** ** **
Figure 4 A
- Su
v39
Soro
rin - Su
v39
Soro
rin - Su
v39
Soro
rin- Su
v39
Soro
rin
- Su
v39
Soro
rin -
Doub
le
Suv3
9 So
rorin
0
10
20
30
40
50
-
Doub
le
Suv3
9 So
rorin
-
Doub
le
Suv3
9 So
rorin
Published graph(fig. S6)
Incorrect error bars
Corrected graph(fig. S6)
Fig. 1A�
Science 349, 1237-1240 (2015)
0%
50%
100%100
50
0
Anap
hase
seg
rega
tion
erro
rs (%
) StructureAttachment
HT10
80
HeLa
-3
293T
A172
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
SW48
0Lo
voHT
29Ca
co2
Attachment defect
CIN+
Structure defect
Figure S6
0102030405060
(i) H3K9me3 defective
Atta
chm
ent d
efec
t (%
)
A
0102030405060
HCC1937(BRCA1)
MCF7HeLa-2 HeLa-3 GM637
- Su
v39
Soro
rin
**
**
***
Figure 4 A
- Su
v39
Soro
rin - Su
v39
Soro
rin - Su
v39
Soro
rin- Su
v39
Soro
rin
01020304050
01020304050
293TU2OSA431
(iii) Doubly defective
Atta
chm
ent d
efec
t (%
)
HCT116(siRB)
(ii) Cohesindefective
Atta
chm
ent d
efec
t (%
)
0
10
20
30
40
50
**** ** **
- Su
v39
Soro
rin -
Doub
le
Suv3
9 So
rorin
0
10
20
30
40
50
-
Doub
le
Suv3
9 So
rorin
-
Doub
le
Suv3
9 So
rorin
****
*
Original graph and data(before revision)�Published graph Corrected graph
(all ± SEM)
In summary, both ICS network defects and mi-totic segregation errors are rescued by restor-ing H3K9me3 and/or cohesin in seven of nineCIN+ cells, which suggests that these two path-ways are important CIN-susceptible targets inhuman cells.Our study reveals that impairment in the ICS
network prevails among human CIN+ cell linesand acts as a key molecular mechanism to gen-erate CIN. Although numerous cellularmutationsmay influence chromosome segregation, onlymu-tations that moderately impair chromosome seg-regationwill establish CIN+ cells, which divide butexhibit genomic instability. In fact, the depletionof a core component of the ICS network (BUB1,SGO1, or the CPC) from cells provokes seriousmitotic defects that lead to lethalmitosis, whereashypomorphicmutations in the ICS network com-ponents cause CIN in cultured human cells andpromote tumorigenesis in mice (28, 29). None-
theless, mutations in components of the ICSnetwork (BUB1, SGO1, CPC) are rare in humancancer genomes (30), implying that the path-ways regulating the ICS network, rather than itscore components, might be genetically or epi-genetically alteredduring tumorigenesis. Indeed,we detected an ICS network defect associatedwith chromosome segregation errors in a patientwith non–small cell lung cancer (fig. S16). Futurestudies, including the inspection of a substantialnumber of clinical samples, will validate the po-tential linkage between ICS network defects andCIN in tumors.
REFERENCES AND NOTES
1. C. Lengauer, K. W. Kinzler, B. Vogelstein, Nature 396, 643–649(1998).
2. R. A. Burrell, N. McGranahan, J. Bartek, C. Swanton, Nature501, 338–345 (2013).
3. N. J. Ganem, S. A. Godinho, D. Pellman, Nature 460, 278–282(2009).
4. T. D. Barber et al., Proc. Natl. Acad. Sci. U.S.A. 105,3443–3448 (2008).
5. S. F. Bakhoum, G. Genovese, D. A. Compton, Curr. Biol. 19,1937–1942 (2009).
6. D. Cimini et al., J. Cell Biol. 153, 517–527 (2001).7. S. L. Thompson, D. A. Compton, J. Cell Biol. 180, 665–672
(2008).8. R. A. Burrell et al., Nature 494, 492–496 (2013).9. S. F. Bakhoum et al., Curr. Biol. 24, R148–R149 (2014).10. K. E. Gascoigne, S. S. Taylor, Cancer Cell 14, 111–122
(2008).11. D. A. Solomon et al., Science 333, 1039–1043 (2011).12. J. R. Daum et al., Curr. Biol. 21, 1018–1024 (2011).13. M. A. Lampson, I. M. Cheeseman, Trends Cell Biol. 21, 133–140
(2011).14. T. U. Tanaka, EMBO J. 29, 4070–4082 (2010).15. Y. Watanabe, Nat. Rev. Mol. Cell Biol. 13, 370–382 (2012).16. T. S. Kitajima et al., Nature 441, 46–52 (2006).17. Y. Tanno et al., Genes Dev. 24, 2169–2179 (2010).18. J. Lee et al., Nat. Cell Biol. 10, 42–52 (2008).19. K. J. Salimian et al., Curr. Biol. 21, 1158–1165 (2011).20. Y. Yamagishi, T. Sakuno, M. Shimura, Y. Watanabe, Nature
455, 251–255 (2008).21. T. Hirota, J. J. Lipp, B. H. Toh, J. M. Peters, Nature 438,
1176–1180 (2005).22. A. L. Nielsen et al., Mol. Cell 7, 729–739 (2001).23. P. A. Cloos et al., Nature 442, 307–311 (2006).24. H. Liu, L. Jia, H. Yu, Curr. Biol. 23, 1927–1933 (2013).25. J. M. Peters, A. Tedeschi, J. Schmitz, Genes Dev. 22,
3089–3114 (2008).26. M. L. Suvà, N. Riggi, B. E. Bernstein, Science 339, 1567–1570
(2013).27. T. Nishiyama et al., Cell 143, 737–749 (2010).28. K. Jeganathan, L. Malureanu, D. J. Baker, S. C. Abraham,
J. M. van Deursen, J. Cell Biol. 179, 255–267 (2007).29. H. Y. Yamada et al., Cell Cycle 11, 479–488 (2012).30. M. S. Lawrence et al., Nature 505, 495–501 (2014).
ACKNOWLEDGMENTS
We thank S. Hauf for critically reading the manuscript; T. Akiyama,Y. Gotoh, K. Shirahige, T. Hirota, K. Miyagawa, A. Enomoto,M. Ohsugi, T. Kitamura, H. Suzuki, and T. Ohta for kindly providingmaterials; K. Funai for clinical arrangements; Y. Hirabayashi,Y. Kanki, S. Koitabashi, M. Okada, T. Kahyo, A. R. Maia, R. Nakato,and D. Izawa for valuable technical advice; and all members of ourlaboratory, particularly Y. Yamagishi, for their valuable support anddiscussions. Supported by JSPS KAKENHI grants 24770180 and26440093 (Y.T.), a JSPS research fellowship (H. Sus.), and MEXTKAKENHI grants S-001 (H. Sug.) and 25000014 (Y.W.).
SUPPLEMENTARY MATERIALS
www.sciencemag.org/content/349/6253/1237/suppl/DC1Materials and MethodsFigs. S1 to S16References (31–40)
10 November 2014; accepted 5 August 201510.1126/science.aaa2655
1240 11 SEPTEMBER 2015 • VOL 349 ISSUE 6253 sciencemag.org SCIENCE
Fig. 4. Promotion of H3K9me3 andcohesin association with chromatinsuppress CIN. (A) The percentage ofanaphases showing attachment defectswas measured in the indicated cellsexpressing HA-Suv39H1-CENP-B and/orGFP-sororin. Error bars, SEM from threeindependent experiments. **P < 0.01,***P < 0.001, one-way ANOVA withBonferroni’s multiple comparisons test
relative to non-expressing cells. (B) Suppression of ICS network defects and CIN in various CIN+ cell lineswith defects (–) in H3K9me3 and chromatin-associated cohesin. The solid box indicates the suppression.
RESEARCH | REPORTSCorrected 18 September 2015; see full text.
Incorrect error bars
(± SD)
(± SD)
Figure 4A
Figure 2A
11.21.41.61.82
2.2
RPE1
HCT1
16He
La-1
HT10
80
HeLa
-3
293T
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
CIN- CIN+ (Attachment defect)
HP1α level in metaphase (centromere/arm)
* * * * *
* * * * * * * * * * * *
* * * * * * *
1.01.2
2.02.2
1.41.61.8
Corrected graph
11.21.41.61.82
2.2
RPE1
HCT1
16He
La-1
HT10
80
HeLa
-3
293T
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
CIN- CIN+ (Attachment defect)
HP1α level in metaphase (centromere/arm)
* * * * * * * * * * * * * * * *
* * * * * *
* *
1.01.2
2.02.2
1.41.62.2
Published graph
Incorrect error bars
Published graph(± SEM)
Corrected graph(± SD)
fig S13D
Science 349, 1237-1240 (2015)
0%
50%
100%100
50
0
Anap
hase
seg
rega
tion
erro
rs (%
) StructureAttachment
HT10
80
HeLa
-3
293T
A172
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
SW48
0Lo
voHT
29Ca
co2
Attachment defect
CIN+
Structure defect
Figure S6
0102030405060
(i) H3K9me3 defective
Atta
chm
ent d
efec
t (%
)
A
0102030405060
HCC1937(BRCA1)
MCF7HeLa-2 HeLa-3 GM637
- Su
v39
Soro
rin
**
**
***
Figure 4 A
- Su
v39
Soro
rin - Su
v39
Soro
rin - Su
v39
Soro
rin- Su
v39
Soro
rin
01020304050
01020304050
293TU2OSA431
(iii) Doubly defective
Atta
chm
ent d
efec
t (%
)
HCT116(siRB)
(ii) Cohesindefective
Atta
chm
ent d
efec
t (%
)
0
10
20
30
40
50
**** ** **
- Su
v39
Soro
rin -
Doub
le
Suv3
9 So
rorin
0
10
20
30
40
50-
Doub
le
Suv3
9 So
rorin
-
Doub
le
Suv3
9 So
rorin
****
*
Published graph Corrected graph(all ± SEM)
In summary, both ICS network defects and mi-totic segregation errors are rescued by restor-ing H3K9me3 and/or cohesin in seven of nineCIN+ cells, which suggests that these two path-ways are important CIN-susceptible targets inhuman cells.Our study reveals that impairment in the ICS
network prevails among human CIN+ cell linesand acts as a key molecular mechanism to gen-erate CIN. Although numerous cellularmutationsmay influence chromosome segregation, onlymu-tations that moderately impair chromosome seg-regationwill establish CIN+ cells, which divide butexhibit genomic instability. In fact, the depletionof a core component of the ICS network (BUB1,SGO1, or the CPC) from cells provokes seriousmitotic defects that lead to lethalmitosis, whereashypomorphicmutations in the ICS network com-ponents cause CIN in cultured human cells andpromote tumorigenesis in mice (28, 29). None-
theless, mutations in components of the ICSnetwork (BUB1, SGO1, CPC) are rare in humancancer genomes (30), implying that the path-ways regulating the ICS network, rather than itscore components, might be genetically or epi-genetically alteredduring tumorigenesis. Indeed,we detected an ICS network defect associatedwith chromosome segregation errors in a patientwith non–small cell lung cancer (fig. S16). Futurestudies, including the inspection of a substantialnumber of clinical samples, will validate the po-tential linkage between ICS network defects andCIN in tumors.
REFERENCES AND NOTES
1. C. Lengauer, K. W. Kinzler, B. Vogelstein, Nature 396, 643–649(1998).
2. R. A. Burrell, N. McGranahan, J. Bartek, C. Swanton, Nature501, 338–345 (2013).
3. N. J. Ganem, S. A. Godinho, D. Pellman, Nature 460, 278–282(2009).
4. T. D. Barber et al., Proc. Natl. Acad. Sci. U.S.A. 105,3443–3448 (2008).
5. S. F. Bakhoum, G. Genovese, D. A. Compton, Curr. Biol. 19,1937–1942 (2009).
6. D. Cimini et al., J. Cell Biol. 153, 517–527 (2001).7. S. L. Thompson, D. A. Compton, J. Cell Biol. 180, 665–672
(2008).8. R. A. Burrell et al., Nature 494, 492–496 (2013).9. S. F. Bakhoum et al., Curr. Biol. 24, R148–R149 (2014).10. K. E. Gascoigne, S. S. Taylor, Cancer Cell 14, 111–122
(2008).11. D. A. Solomon et al., Science 333, 1039–1043 (2011).12. J. R. Daum et al., Curr. Biol. 21, 1018–1024 (2011).13. M. A. Lampson, I. M. Cheeseman, Trends Cell Biol. 21, 133–140
(2011).14. T. U. Tanaka, EMBO J. 29, 4070–4082 (2010).15. Y. Watanabe, Nat. Rev. Mol. Cell Biol. 13, 370–382 (2012).16. T. S. Kitajima et al., Nature 441, 46–52 (2006).17. Y. Tanno et al., Genes Dev. 24, 2169–2179 (2010).18. J. Lee et al., Nat. Cell Biol. 10, 42–52 (2008).19. K. J. Salimian et al., Curr. Biol. 21, 1158–1165 (2011).20. Y. Yamagishi, T. Sakuno, M. Shimura, Y. Watanabe, Nature
455, 251–255 (2008).21. T. Hirota, J. J. Lipp, B. H. Toh, J. M. Peters, Nature 438,
1176–1180 (2005).22. A. L. Nielsen et al., Mol. Cell 7, 729–739 (2001).23. P. A. Cloos et al., Nature 442, 307–311 (2006).24. H. Liu, L. Jia, H. Yu, Curr. Biol. 23, 1927–1933 (2013).25. J. M. Peters, A. Tedeschi, J. Schmitz, Genes Dev. 22,
3089–3114 (2008).26. M. L. Suvà, N. Riggi, B. E. Bernstein, Science 339, 1567–1570
(2013).27. T. Nishiyama et al., Cell 143, 737–749 (2010).28. K. Jeganathan, L. Malureanu, D. J. Baker, S. C. Abraham,
J. M. van Deursen, J. Cell Biol. 179, 255–267 (2007).29. H. Y. Yamada et al., Cell Cycle 11, 479–488 (2012).30. M. S. Lawrence et al., Nature 505, 495–501 (2014).
ACKNOWLEDGMENTS
We thank S. Hauf for critically reading the manuscript; T. Akiyama,Y. Gotoh, K. Shirahige, T. Hirota, K. Miyagawa, A. Enomoto,M. Ohsugi, T. Kitamura, H. Suzuki, and T. Ohta for kindly providingmaterials; K. Funai for clinical arrangements; Y. Hirabayashi,Y. Kanki, S. Koitabashi, M. Okada, T. Kahyo, A. R. Maia, R. Nakato,and D. Izawa for valuable technical advice; and all members of ourlaboratory, particularly Y. Yamagishi, for their valuable support anddiscussions. Supported by JSPS KAKENHI grants 24770180 and26440093 (Y.T.), a JSPS research fellowship (H. Sus.), and MEXTKAKENHI grants S-001 (H. Sug.) and 25000014 (Y.W.).
SUPPLEMENTARY MATERIALS
www.sciencemag.org/content/349/6253/1237/suppl/DC1Materials and MethodsFigs. S1 to S16References (31–40)
10 November 2014; accepted 5 August 201510.1126/science.aaa2655
1240 11 SEPTEMBER 2015 • VOL 349 ISSUE 6253 sciencemag.org SCIENCE
Fig. 4. Promotion of H3K9me3 andcohesin association with chromatinsuppress CIN. (A) The percentage ofanaphases showing attachment defectswas measured in the indicated cellsexpressing HA-Suv39H1-CENP-B and/orGFP-sororin. Error bars, SEM from threeindependent experiments. **P < 0.01,***P < 0.001, one-way ANOVA withBonferroni’s multiple comparisons test
relative to non-expressing cells. (B) Suppression of ICS network defects and CIN in various CIN+ cell lineswith defects (–) in H3K9me3 and chromatin-associated cohesin. The solid box indicates the suppression.
RESEARCH | REPORTSCorrected 18 September 2015; see full text.
Incorrect error bars
(± SD)
(± SD)
Fig 4A Fig 2A Published graph
Cells
with
coh
esio
n lo
ss a
fter
MG
132
arre
st (%
)
0
100
25
50
75
H4
HCT116
Cont
rol
siRAD
21
* * *
Co ntro l
s iS cc 1 H
4
0
2 5
5 0
7 5
1 0 0
Cells
with
coh
esio
n lo
ss a
fter
MG
132
arre
st (%
)
0
100
25
50
75
H4
HCT116
Cont
rol
siRAD
21
* * *
Published graph(± SEM)
Corrected graph(± SD)
fig. S13��fig. S6�
0%
50%
100%100
50
0
Anap
hase
seg
rega
tion
erro
rs (%
) StructureAttachment
HT10
80
HeLa
-3
293T
A172
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
SW48
0Lo
voHT
29Ca
co2
Attachment defect
CIN+
Structure defect
Figure S6
01020304050
01020304050
0102030405060
293TU2OSA431
(iii) Doubly defective
Atta
chm
ent d
efec
t (%
)
(i) H3K9me3 defective
Atta
chm
ent d
efec
t (%
)
A
0102030405060
HCC1937(BRCA1)
MCF7HeLa-2 HeLa-3 GM637
- Su
v39
Soro
rin
HCT116(siRB)
(ii) Cohesindefective
Atta
chm
ent d
efec
t (%
)
0
10
20
30
40
50
******
**
***
**** ** **
Figure 4 A
- Su
v39
Soro
rin - Su
v39
Soro
rin - Su
v39
Soro
rin- Su
v39
Soro
rin
- Su
v39
Soro
rin -
Doub
le
Suv3
9 So
rorin
0
10
20
30
40
50
-
Doub
le
Suv3
9 So
rorin
-
Doub
le
Suv3
9 So
rorin
Published graph(fig. S6)
Incorrect error bars
Corrected graph(fig. S6)
Fig. 1A�
Science 349, 1237-1240 (2015)
0%
50%
100%100
50
0
Anap
hase
seg
rega
tion
erro
rs (%
) StructureAttachment
HT10
80
HeLa
-3
293T
A172
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
SW48
0Lo
voHT
29Ca
co2
Attachment defect
CIN+
Structure defect
Figure S6
0102030405060
(i) H3K9me3 defective
Atta
chm
ent d
efec
t (%
)
A
0102030405060
HCC1937(BRCA1)
MCF7HeLa-2 HeLa-3 GM637
- Su
v39
Soro
rin
**
**
***
Figure 4 A
- Su
v39
Soro
rin - Su
v39
Soro
rin - Su
v39
Soro
rin- Su
v39
Soro
rin
01020304050
01020304050
293TU2OSA431
(iii) Doubly defective
Atta
chm
ent d
efec
t (%
)
HCT116(siRB)
(ii) Cohesindefective
Atta
chm
ent d
efec
t (%
)
0
10
20
30
40
50
**** ** **
- Su
v39
Soro
rin -
Doub
le
Suv3
9 So
rorin
0
10
20
30
40
50
-
Doub
le
Suv3
9 So
rorin
-
Doub
le
Suv3
9 So
rorin
****
*
Original graph and data(before revision)�Published graph Corrected graph
(all ± SEM)
In summary, both ICS network defects and mi-totic segregation errors are rescued by restor-ing H3K9me3 and/or cohesin in seven of nineCIN+ cells, which suggests that these two path-ways are important CIN-susceptible targets inhuman cells.Our study reveals that impairment in the ICS
network prevails among human CIN+ cell linesand acts as a key molecular mechanism to gen-erate CIN. Although numerous cellularmutationsmay influence chromosome segregation, onlymu-tations that moderately impair chromosome seg-regationwill establish CIN+ cells, which divide butexhibit genomic instability. In fact, the depletionof a core component of the ICS network (BUB1,SGO1, or the CPC) from cells provokes seriousmitotic defects that lead to lethalmitosis, whereashypomorphicmutations in the ICS network com-ponents cause CIN in cultured human cells andpromote tumorigenesis in mice (28, 29). None-
theless, mutations in components of the ICSnetwork (BUB1, SGO1, CPC) are rare in humancancer genomes (30), implying that the path-ways regulating the ICS network, rather than itscore components, might be genetically or epi-genetically alteredduring tumorigenesis. Indeed,we detected an ICS network defect associatedwith chromosome segregation errors in a patientwith non–small cell lung cancer (fig. S16). Futurestudies, including the inspection of a substantialnumber of clinical samples, will validate the po-tential linkage between ICS network defects andCIN in tumors.
REFERENCES AND NOTES
1. C. Lengauer, K. W. Kinzler, B. Vogelstein, Nature 396, 643–649(1998).
2. R. A. Burrell, N. McGranahan, J. Bartek, C. Swanton, Nature501, 338–345 (2013).
3. N. J. Ganem, S. A. Godinho, D. Pellman, Nature 460, 278–282(2009).
4. T. D. Barber et al., Proc. Natl. Acad. Sci. U.S.A. 105,3443–3448 (2008).
5. S. F. Bakhoum, G. Genovese, D. A. Compton, Curr. Biol. 19,1937–1942 (2009).
6. D. Cimini et al., J. Cell Biol. 153, 517–527 (2001).7. S. L. Thompson, D. A. Compton, J. Cell Biol. 180, 665–672
(2008).8. R. A. Burrell et al., Nature 494, 492–496 (2013).9. S. F. Bakhoum et al., Curr. Biol. 24, R148–R149 (2014).10. K. E. Gascoigne, S. S. Taylor, Cancer Cell 14, 111–122
(2008).11. D. A. Solomon et al., Science 333, 1039–1043 (2011).12. J. R. Daum et al., Curr. Biol. 21, 1018–1024 (2011).13. M. A. Lampson, I. M. Cheeseman, Trends Cell Biol. 21, 133–140
(2011).14. T. U. Tanaka, EMBO J. 29, 4070–4082 (2010).15. Y. Watanabe, Nat. Rev. Mol. Cell Biol. 13, 370–382 (2012).16. T. S. Kitajima et al., Nature 441, 46–52 (2006).17. Y. Tanno et al., Genes Dev. 24, 2169–2179 (2010).18. J. Lee et al., Nat. Cell Biol. 10, 42–52 (2008).19. K. J. Salimian et al., Curr. Biol. 21, 1158–1165 (2011).20. Y. Yamagishi, T. Sakuno, M. Shimura, Y. Watanabe, Nature
455, 251–255 (2008).21. T. Hirota, J. J. Lipp, B. H. Toh, J. M. Peters, Nature 438,
1176–1180 (2005).22. A. L. Nielsen et al., Mol. Cell 7, 729–739 (2001).23. P. A. Cloos et al., Nature 442, 307–311 (2006).24. H. Liu, L. Jia, H. Yu, Curr. Biol. 23, 1927–1933 (2013).25. J. M. Peters, A. Tedeschi, J. Schmitz, Genes Dev. 22,
3089–3114 (2008).26. M. L. Suvà, N. Riggi, B. E. Bernstein, Science 339, 1567–1570
(2013).27. T. Nishiyama et al., Cell 143, 737–749 (2010).28. K. Jeganathan, L. Malureanu, D. J. Baker, S. C. Abraham,
J. M. van Deursen, J. Cell Biol. 179, 255–267 (2007).29. H. Y. Yamada et al., Cell Cycle 11, 479–488 (2012).30. M. S. Lawrence et al., Nature 505, 495–501 (2014).
ACKNOWLEDGMENTS
We thank S. Hauf for critically reading the manuscript; T. Akiyama,Y. Gotoh, K. Shirahige, T. Hirota, K. Miyagawa, A. Enomoto,M. Ohsugi, T. Kitamura, H. Suzuki, and T. Ohta for kindly providingmaterials; K. Funai for clinical arrangements; Y. Hirabayashi,Y. Kanki, S. Koitabashi, M. Okada, T. Kahyo, A. R. Maia, R. Nakato,and D. Izawa for valuable technical advice; and all members of ourlaboratory, particularly Y. Yamagishi, for their valuable support anddiscussions. Supported by JSPS KAKENHI grants 24770180 and26440093 (Y.T.), a JSPS research fellowship (H. Sus.), and MEXTKAKENHI grants S-001 (H. Sug.) and 25000014 (Y.W.).
SUPPLEMENTARY MATERIALS
www.sciencemag.org/content/349/6253/1237/suppl/DC1Materials and MethodsFigs. S1 to S16References (31–40)
10 November 2014; accepted 5 August 201510.1126/science.aaa2655
1240 11 SEPTEMBER 2015 • VOL 349 ISSUE 6253 sciencemag.org SCIENCE
Fig. 4. Promotion of H3K9me3 andcohesin association with chromatinsuppress CIN. (A) The percentage ofanaphases showing attachment defectswas measured in the indicated cellsexpressing HA-Suv39H1-CENP-B and/orGFP-sororin. Error bars, SEM from threeindependent experiments. **P < 0.01,***P < 0.001, one-way ANOVA withBonferroni’s multiple comparisons test
relative to non-expressing cells. (B) Suppression of ICS network defects and CIN in various CIN+ cell lineswith defects (–) in H3K9me3 and chromatin-associated cohesin. The solid box indicates the suppression.
RESEARCH | REPORTSCorrected 18 September 2015; see full text.
Incorrect error bars
(± SD)
(± SD)
Figure 4A
Figure 2A
11.21.41.61.82
2.2
RPE1
HCT1
16He
La-1
HT10
80
HeLa
-3
293T
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
CIN- CIN+ (Attachment defect)
HP1α level in metaphase (centromere/arm)
* * * * *
* * * * * * * * * * * *
* * * * * * *
1.01.2
2.02.2
1.41.61.8
Corrected graph
11.21.41.61.82
2.2
RPE1
HCT1
16He
La-1
HT10
80
HeLa
-3
293T
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
CIN- CIN+ (Attachment defect)
HP1α level in metaphase (centromere/arm)
* * * * * * * * * * * * * * * *
* * * * * *
* *
1.01.2
2.02.2
1.41.62.2
Published graph
Incorrect error bars
Cells
with
coh
esio
n lo
ss a
fter
MG
132
arre
st (%
)
0
100
25
50
75
H4
HCT116
Cont
rol
siRAD
21
* * *
Co ntro l
s iS cc 1 H
4
0
2 5
5 0
7 5
1 0 0
Cells
with
coh
esio
n lo
ss a
fter
MG
132
arre
st (%
)
0
100
25
50
75
H4
HCT116
Cont
rol
siRAD
21
* * *
Published graph(± SEM)
Corrected graph(± SD)
fig. S13��fig. S6�
0%
50%
100%100
50
0
Anap
hase
seg
rega
tion
erro
rs (%
) StructureAttachment
HT10
80
HeLa
-3
293T
A172
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
SW48
0Lo
voHT
29Ca
co2
Attachment defect
CIN+
Structure defect
Figure S6
01020304050
01020304050
0102030405060
293TU2OSA431
(iii) Doubly defective
Atta
chm
ent d
efec
t (%
)
(i) H3K9me3 defective
Atta
chm
ent d
efec
t (%
)
A
0102030405060
HCC1937(BRCA1)
MCF7HeLa-2 HeLa-3 GM637
- Su
v39
Soro
rin
HCT116(siRB)
(ii) Cohesindefective
Atta
chm
ent d
efec
t (%
)
0
10
20
30
40
50
******
**
***
**** ** **
Figure 4 A
- Su
v39
Soro
rin - Su
v39
Soro
rin - Su
v39
Soro
rin- Su
v39
Soro
rin
- Su
v39
Soro
rin -
Doub
le
Suv3
9 So
rorin
0
10
20
30
40
50
-
Doub
le
Suv3
9 So
rorin
-
Doub
le
Suv3
9 So
rorin
Published graph(fig. S6)
Incorrect error bars
Corrected graph(fig. S6)
Fig. 1A�
Science 349, 1237-1240 (2015)
0%
50%
100%100
50
0
Anap
hase
seg
rega
tion
erro
rs (%
) StructureAttachment
HT10
80
HeLa
-3
293T
A172
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
SW48
0Lo
voHT
29Ca
co2
Attachment defect
CIN+
Structure defect
Figure S6
0102030405060
(i) H3K9me3 defective
Atta
chm
ent d
efec
t (%
)
A
0102030405060
HCC1937(BRCA1)
MCF7HeLa-2 HeLa-3 GM637
- Su
v39
Soro
rin
**
**
***
Figure 4 A
- Su
v39
Soro
rin - Su
v39
Soro
rin - Su
v39
Soro
rin- Su
v39
Soro
rin
01020304050
01020304050
293TU2OSA431
(iii) Doubly defective
Atta
chm
ent d
efec
t (%
)
HCT116(siRB)
(ii) Cohesindefective
Atta
chm
ent d
efec
t (%
)
0
10
20
30
40
50
**** ** **
- Su
v39
Soro
rin -
Doub
le
Suv3
9 So
rorin
0
10
20
30
40
50
-
Doub
le
Suv3
9 So
rorin
-
Doub
le
Suv3
9 So
rorin
****
*
Original graph and data(before revision)�Published graph Corrected graph
(all ± SEM)
In summary, both ICS network defects and mi-totic segregation errors are rescued by restor-ing H3K9me3 and/or cohesin in seven of nineCIN+ cells, which suggests that these two path-ways are important CIN-susceptible targets inhuman cells.Our study reveals that impairment in the ICS
network prevails among human CIN+ cell linesand acts as a key molecular mechanism to gen-erate CIN. Although numerous cellularmutationsmay influence chromosome segregation, onlymu-tations that moderately impair chromosome seg-regationwill establish CIN+ cells, which divide butexhibit genomic instability. In fact, the depletionof a core component of the ICS network (BUB1,SGO1, or the CPC) from cells provokes seriousmitotic defects that lead to lethalmitosis, whereashypomorphicmutations in the ICS network com-ponents cause CIN in cultured human cells andpromote tumorigenesis in mice (28, 29). None-
theless, mutations in components of the ICSnetwork (BUB1, SGO1, CPC) are rare in humancancer genomes (30), implying that the path-ways regulating the ICS network, rather than itscore components, might be genetically or epi-genetically alteredduring tumorigenesis. Indeed,we detected an ICS network defect associatedwith chromosome segregation errors in a patientwith non–small cell lung cancer (fig. S16). Futurestudies, including the inspection of a substantialnumber of clinical samples, will validate the po-tential linkage between ICS network defects andCIN in tumors.
REFERENCES AND NOTES
1. C. Lengauer, K. W. Kinzler, B. Vogelstein, Nature 396, 643–649(1998).
2. R. A. Burrell, N. McGranahan, J. Bartek, C. Swanton, Nature501, 338–345 (2013).
3. N. J. Ganem, S. A. Godinho, D. Pellman, Nature 460, 278–282(2009).
4. T. D. Barber et al., Proc. Natl. Acad. Sci. U.S.A. 105,3443–3448 (2008).
5. S. F. Bakhoum, G. Genovese, D. A. Compton, Curr. Biol. 19,1937–1942 (2009).
6. D. Cimini et al., J. Cell Biol. 153, 517–527 (2001).7. S. L. Thompson, D. A. Compton, J. Cell Biol. 180, 665–672
(2008).8. R. A. Burrell et al., Nature 494, 492–496 (2013).9. S. F. Bakhoum et al., Curr. Biol. 24, R148–R149 (2014).10. K. E. Gascoigne, S. S. Taylor, Cancer Cell 14, 111–122
(2008).11. D. A. Solomon et al., Science 333, 1039–1043 (2011).12. J. R. Daum et al., Curr. Biol. 21, 1018–1024 (2011).13. M. A. Lampson, I. M. Cheeseman, Trends Cell Biol. 21, 133–140
(2011).14. T. U. Tanaka, EMBO J. 29, 4070–4082 (2010).15. Y. Watanabe, Nat. Rev. Mol. Cell Biol. 13, 370–382 (2012).16. T. S. Kitajima et al., Nature 441, 46–52 (2006).17. Y. Tanno et al., Genes Dev. 24, 2169–2179 (2010).18. J. Lee et al., Nat. Cell Biol. 10, 42–52 (2008).19. K. J. Salimian et al., Curr. Biol. 21, 1158–1165 (2011).20. Y. Yamagishi, T. Sakuno, M. Shimura, Y. Watanabe, Nature
455, 251–255 (2008).21. T. Hirota, J. J. Lipp, B. H. Toh, J. M. Peters, Nature 438,
1176–1180 (2005).22. A. L. Nielsen et al., Mol. Cell 7, 729–739 (2001).23. P. A. Cloos et al., Nature 442, 307–311 (2006).24. H. Liu, L. Jia, H. Yu, Curr. Biol. 23, 1927–1933 (2013).25. J. M. Peters, A. Tedeschi, J. Schmitz, Genes Dev. 22,
3089–3114 (2008).26. M. L. Suvà, N. Riggi, B. E. Bernstein, Science 339, 1567–1570
(2013).27. T. Nishiyama et al., Cell 143, 737–749 (2010).28. K. Jeganathan, L. Malureanu, D. J. Baker, S. C. Abraham,
J. M. van Deursen, J. Cell Biol. 179, 255–267 (2007).29. H. Y. Yamada et al., Cell Cycle 11, 479–488 (2012).30. M. S. Lawrence et al., Nature 505, 495–501 (2014).
ACKNOWLEDGMENTS
We thank S. Hauf for critically reading the manuscript; T. Akiyama,Y. Gotoh, K. Shirahige, T. Hirota, K. Miyagawa, A. Enomoto,M. Ohsugi, T. Kitamura, H. Suzuki, and T. Ohta for kindly providingmaterials; K. Funai for clinical arrangements; Y. Hirabayashi,Y. Kanki, S. Koitabashi, M. Okada, T. Kahyo, A. R. Maia, R. Nakato,and D. Izawa for valuable technical advice; and all members of ourlaboratory, particularly Y. Yamagishi, for their valuable support anddiscussions. Supported by JSPS KAKENHI grants 24770180 and26440093 (Y.T.), a JSPS research fellowship (H. Sus.), and MEXTKAKENHI grants S-001 (H. Sug.) and 25000014 (Y.W.).
SUPPLEMENTARY MATERIALS
www.sciencemag.org/content/349/6253/1237/suppl/DC1Materials and MethodsFigs. S1 to S16References (31–40)
10 November 2014; accepted 5 August 201510.1126/science.aaa2655
1240 11 SEPTEMBER 2015 • VOL 349 ISSUE 6253 sciencemag.org SCIENCE
Fig. 4. Promotion of H3K9me3 andcohesin association with chromatinsuppress CIN. (A) The percentage ofanaphases showing attachment defectswas measured in the indicated cellsexpressing HA-Suv39H1-CENP-B and/orGFP-sororin. Error bars, SEM from threeindependent experiments. **P < 0.01,***P < 0.001, one-way ANOVA withBonferroni’s multiple comparisons test
relative to non-expressing cells. (B) Suppression of ICS network defects and CIN in various CIN+ cell lineswith defects (–) in H3K9me3 and chromatin-associated cohesin. The solid box indicates the suppression.
RESEARCH | REPORTSCorrected 18 September 2015; see full text.
Incorrect error bars
(± SD)
(± SD)
Figure 4A
Figure 2A
11.21.41.61.82
2.2
RPE1
HCT1
16He
La-1
HT10
80
HeLa
-3
293T
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
CIN- CIN+ (Attachment defect)
HP1α level in metaphase (centromere/arm)
* * * * *
* * * * * * * * * * * *
* * * * * * *
1.01.2
2.02.2
1.41.61.8
Corrected graph
11.21.41.61.82
2.2
RPE1
HCT1
16He
La-1
HT10
80
HeLa
-3
293T
A431
HeLa
-2
GM
637
MCF
7
U2O
ST4
7D
CIN- CIN+ (Attachment defect)
HP1α level in metaphase (centromere/arm)
* * * * * * * * * * * * * * * *
* * * * * *
* *
1.01.2
2.02.2
1.41.62.2
Published graph
Incorrect error bars
Incorrect error bars
Corrected graph
We additionally made some inadvertent mistakes (due to a mistake in our use of the graph software) in adding error bars in Fig. 2A, 4A, S6 and S13D, while preparing or revising the manuscript. We have confirmed that the statistical analyses are all valid, as they were performed on the original data. The errors are corrected here. We apologize for any confusion that these errors may have caused.
fig S12B Published Correction or retraction of the figure
fig S6
Incorrect error bars
Published graph Corrected graph
FigS12B�
Correctlyadjusted(retryat21May)�
Published�
Control� siRB� siBRCA1�
RAD
21
DN
A�Au
rora
B�
G1 G2 G1 G2 G1 G2
HCT116 B
Control� siRB� siBRCA1�
RAD
21
DN
A�Au
rora
B�
G1 G2 G1 G2 G1 G2
HCT116 B
FigS12B�
Correctlyadjusted(retryat21May)�
Published�
Control� siRB� siBRCA1�
RAD
21
DN
A�Au
rora
B�
G1 G2 G1 G2 G1 G2
HCT116 B
Control� siRB� siBRCA1�
RAD
21
DN
A�Au
rora
B�
G1 G2 G1 G2 G1 G2
HCT116 B